Results 261 to 270 of about 80,208 (340)
Movement Disorders Clinical Practice, EarlyView.
Matthew Julian Georgiades+7 more
wiley +1 more source
ABSTRACT Background DaxibotulinumtoxinA (DAXI), a novel botulinum neurotoxin (BoNT) formulation, was shown to be safe, effective, and long‐lasting in the treatment of cervical dystonia (CD) over one treatment cycle in the phase 3, randomized, placebo‐controlled ASPEN‐1 trial.
Peter McAllister+11 more
wiley +1 more source
Six Myths and Misconceptions about Essential Tremor. [PDF]
Louis ED.
europepmc +1 more source
Adult‐Onset Dystonia‐Parkinsonism: Do Not Forget SERAC1
Movement Disorders Clinical Practice, EarlyView.
Giulia Scacciatella+15 more
wiley +1 more source
Abstract Background Deep brain stimulation (DBS) targeting the subthalamic nucleus (STN) can effectively treat motor symptoms of Parkinson's disease (PD). However, optimal patient selection remains challenging due to the inadequacy of outcome predictors.
John R. Younce+3 more
wiley +1 more source
Therapeutic Potential of Agmatine in Essential Tremor Through Regulation of Lingo-1 and Inflammatory Pathways. [PDF]
Pirmoradi Z+6 more
europepmc +1 more source
Ultrasound-Guided Botulinum Toxin Infiltrations in Essential Tremor Patients: A 36-week Follow Up. [PDF]
Salazar G, Caballero I.
europepmc +1 more source
Abstract Background Hereditary spastic paraplegias (HSP) are rare disorders sharing common features of leg spasticity with gait impairment. Simple and complex forms are recognized; over 50% of cases remain unsolved genetically. Little is known about the genetics of HSP among Indigenous Peoples. Objectives To describe clinical, radiological, and genetic
Ekhlas Assaedi+7 more
wiley +1 more source
Essential tremor plus affects disease prognosis: A longitudinal study. [PDF]
He R+13 more
europepmc +1 more source